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reaction toward 4-(tetrazole)-1,3-oxazinanes†
Ajay L. Chandgude, a Daniele Narducci,a Katarzyna Kurpiewska,b
Justyna Kalinowska-Tłus´cikb and Alexander Do¨mling *a
A diastereoselective one pot ﬁve-component reaction toward the synthesis of 4-(tetrazole)-1,3-oxazinanes
has been reported. The sonication-accelerated, catalyst-free, simple, general and highly time eﬃcient,
Asinger–Ugi-tetrazole reaction was used for the synthesis of diverse 4-(tetrazole)-1,3-oxazinanes. The
reaction exhibit excellent diastereoselectivity and broad substrate scope.Introduction
The oxazine motif attained signicant attention due to their
widespread availability in natural products, such as aragupe-
trosine, bujeine, pagicerine, quimbeline, and upenamide.1 The
oxazines scaﬀold is present in many pharmacologically active
agents and drugs, such as pranlukast, dirithromycin, and
dolutegravir.2 It is also used as intermediate for the synthesis of
drugs like oxacephem antibiotics.2c
On the other hand, the tetrazole is a highly important synthetic
scaﬀold for a wide range of areas and applications. It is extensively
used in medicinal and organic chemistry, also in industries such
as explosives, agrochemicals, materials, and polymers.3 Their use
as a carboxylic acid isostere and cis-amide bond isostere in
peptides have many advantages, such as extra lipophilicity, meta-
bolic stability, and hydrogen bonding to increase potency.4
Heterocycles are important in drug design and are present in half
of the top 200 drugs.5 Thus, recently the use of heterocycle linked
tetrazole scaﬀolds got major attention as a privileged core struc-
ture for the development of drug candidates. This combination is
an eﬀective strategy to balance drug-like properties. Owning the
importance of heterocycles linked tetrazoles resulted into reports
of many examples of bioactive agents, such as pyridine-tetrazole,
Akt1 and Akt2 dual inhibitors;6 pyrazole-tetrazole, anti-
leishmanials7 or as cardiotonic agents;8 pyridine-tetrazole, anti-
bacterial;9 piperazines-tetrazole, type 2 diabetes;10 isoxazole-
tetrazole, for AMPA receptors;11 and also for ionotropic gluta-
mate receptors.12 Moreover, in non-medical applications, use of
cyclic ketimines-tetrazoles as organocatalysts,13 and pyridine-
tetrazoles in lanthanide-based applications14 are also well known.roningen, Antonius Deusinglaan 1, 9713
.s.domling@rug.nl
ry, Department of Crystal Chemistry and
gardena 3, 30-060 Krakow, Poland
(ESI) available. CCDC 1521456 and
a in CIF or other electronic format see
hemistry 2017Strategies for the synthesis of heterocycle-tetrazole can be
categorized into three types. First, the coupling of heterocycle
with tetrazole (Fig. 1A).15 Second, synthesis of cyano-heterocycle
followed by the tetrazole formation (Fig. 1B).7 Third, tetrazole
synthesis followed by post-condensation reaction toward
heterocycle formation (Fig. 1C).16 These methods involve more
than two steps, harsh coupling conditions, and also the
synthesis of starting material for the coupling can be tedious.
Here we are reporting the rst example of an in situ oxazine-
tetrazole motif synthesis by using a one-pot ve-component reac-
tion. The oxazine-tetrazole scaﬀold is accessible in one pot, time
eﬃciently with high diastereoselectivity and diversity.Results and discussion
We envisioned the use of Asinger–Ugi-tetrazole union for the
rst time to synthesize an oxazines-tetrazole scaﬀold. We start
our optimization by using isobutyraldehyde, ammonium
hydroxide, 3-hydroxypivalaldehyde, benzyl isocyanide and
TMSN3. The reaction in methanol at room temperature resulted
in only trace product formation (Table 1, entry 1). Union of an
Asinger reaction with other MCRs is known to be low yielding.17
Therefore we move our attention towards the use of sonication
in MCR which can be highly eﬀective.18 Further optimization
was carried out with sonication at room temperature.
First, we optimized the ammonia source. We screened
diﬀerent ammonia sources, like NH4OH, NH4Cl, and NH4OAc.
NH4OH in 1.5 equivalent was found to be the best. When the
reaction was performed in MeOH, a promising 51% yield was
obtained (Table 1, entry 2). Next, we move our attention towards
solvent screening. Use of MeOH : H2O solvent systems, such as
3 : 1, 1 : 1 or 1 : 3 resulted in less product formation, like 21%,
17%, and 15% respectively (Table 1, entries 3–5). However,
EtOH as solvent gave the desired product only in trace amounts.
When water was used as a solvent, the reaction did not proceed
further probably due to the water insolubility of the reactants
(Table 1, entry 7). Use of dioxane and THF provided a similarRSC Adv., 2017, 7, 49995–49998 | 49995
Fig. 1 In situ bis-heterocycle synthesis.
Table 2 Substrate scopea
Entry R1-CHO R2-NC Yield
b (%) drc
1 (1a) 60 78 : 22
2 (1b) 51 91 : 09
3 (1c) 56 90 : 10
4 (1d) 47 88 : 12






















































































View Article Onlineyield of 30% (Table 1, entries 8–9). TFE and DCM gave lower
yields. Toluene turned out to be the best solvent with 60% yield
(Table 1, entry 13). However, an attempt to make the protocolTable 1 Optimization of reaction conditionsa
Entry Solvent Time (h) Yieldb (%)
1c MeOH 12 Trace
2 MeOH 2 51
3 MeOH : H2O (3 : 1) 4 21
4 MeOH : H2O (1 : 1) 4 17
5 MeOH : H2O (1 : 3) 6 15
6 EtOH 2 nd
7 H2O 7 nr
8 Dioxane 2 32
9 THF 2 29
10 TFE 3 16
11 DCM 3 17
12 MeCN 3 33
13 Toluene 2 60
14 Toluene : H2O (1 : 1) 4 11
15 Toluene : H2O (3 : 1) 3 19
16 Toluene : H2O (4 : 1) 2 25
17 p-Xylene 4 15
a The reaction was carried out with isobutyraldehyde (1 mmol),
ammonium hydroxide (1.5 mmol), 3-hydroxypivalaldehyde (1 mmol),
benzyl isocyanide (1.2 mmol) and TMSN3 (1.2 mmol) in 0.5 ml
solvent. b Yield of isolated product. c Without sonication at room
temperature. nd-not determined. nr-no reaction.
6 (1f) 55 91 : 09
7 (1g) 25 90 : 10
8 (1h) 34 96 : 04
9 (1i) 48 94 : 06
10 (1j) 50 90 : 10
11 (1k) 83 91 : 09
12 (1l) 35 94 : 06
13 (1m) 45 92 : 08
14 (1n) Trace —
a The reaction was carried out with isobutyraldehyde (1mmol), ammonium
hydroxide (1.5 mmol), 3-hydroxypivalaldehyde (1 mmol), benzyl isocyanide
(1.2 mmol) and TMSN3 (1.2 mmol) in 0.5 ml solvent.
b Yield of isolated
product. c dr ratio determined by NMR analysis.
49996 | RSC Adv., 2017, 7, 49995–49998 This journal is © The Royal Society of Chemistry 2017























































































View Article Onlinegreener by using toluene : water solvent system resulted in
a lowering to 25% yield (Table 1, entries 14–16); while xylene did
not ameliorate the reaction yield.
With optimized conditions in hand, next, we tested the scope
and limitations of this reaction by reacting various aldehydes
and isocyanides (Table 2). Diﬀerent linear and branched
aliphatic aldehydes such as isobutyraldehyde, propanal, butyr-
aldehyde, and valeraldehyde provide moderate to good yields of
21% to 60% (Table 2, entries 2–7). Good to excellent yield were
obtained with aliphatic-aromatic aldehydes like benzyl and
phenylacetaldehyde. Benzaldehyde and 2-chloro benzaldehyde
are valid substrates in this reaction with providing moderate
yields of 35% and 45% respectively (Table 2, entries 12 and 13).
However, the reaction with ketone resulted in only trace product
formation. It is important to mention that, the preformation of
imine from aldehyde and ammonium hydroxide is needed to
get high yield which normally requires 30 minutes to 1 hour
preincubation. The slow addition of 3-hydroxypivalaldehyde
over 30 min also helped to get a clean reaction. Aer the addi-
tion of isocyanide and TMSN3, the reaction completes within 2–
4 hours.
Further, we screened diﬀerent isocyanides. Aliphatic iso-
cyanides like tert-octyl isocyanide and cyclohexyl isocyanide
worked well (Table 2, entries 3 and 9). Aromatic isocyanides like
benzyl and phenylethyl isocyanide with diﬀerent aldehydes,
product yields were good. The glycine isocyanide provided the
excellent yield of 83% (Table 2, entry 11). The functional group
protected isocyanide, diethoxy-acetaldehyde was also compat-
ible in this reaction, which is interesting for further post-
modication condensation or for unions with other MCR (Table
2, entry 6). Also, a tolerance of a 2-bromo benzyl isocyanide is
interesting for potential postmodication reactions (Table 2,
entry 4).Fig. 2 X-ray structures of 1b and 1c.
This journal is © The Royal Society of Chemistry 2017In all examples a higher diastereoselectivity was observed.
Aliphatic, aromatic aldehydes and also all isocyanides show
more than 90 : 10 diastereoselectivity. However with benzyl
isocyanide and 2-bromo benzylisocyanides low diaster-
eoselectivity was observed.
The structures have been conrmed by NMR, MS (low and
high resolution) and also by X-ray crystallography (Fig. 2).
Proposed mechanism
Based on the previous reports we proposed the following
mechanism and which could also explain the high diaster-
eoselectivity of this reaction. In this reaction, rst aldehyde,
ammonia and 3-hydroxypivalaldehyde react together to form
the asymmetrically substituted Asinger reaction product, 5,6-
dihydro-2H-1,3-oxazines. With the reference of reported articles
and study we assume that out of the two possible half-chair
conformations with minimal energy I and II, the energetically
preferred half-chair conformation conformer I is strongly fav-
oured.17,19 As the strong steric interactions between one of the
methylene protons in 6-position and substitution on the posi-
tion 2 unavored the conformer II. However, in conformer I this
steric repulsion is reduced by position 6 (Scheme 1).
Next, as per previously published research,20 isocyanide will
preferentially attack axially on the six membered, 5,6-dihydro-
2H-1,3-oxazines to reduce the steric stain to form the interme-
diate III. Followed by azide attack on this intermediate III
formed the nal product in high diastereoselectivity as per
above mentioned reasons like preferable conformers of 5,6-
dihydro-2H-1,3-oxazines and preferred axial attack of
isocyanides.
Conclusions
In conclusion, we have developed a diastereoselective one-pot
ve component reaction for the oxazinane-tetrazoles
synthesis. This sonication-assisted, novel, and general reac-
tion has many advances, such as high time eﬃciency, catalyst-






















































































View Article OnlineMoreover, due to diverse substrate compatibility, this reaction
has a signicant potential for postcondensation reactions to get
more complex and diverse oxazine-tetrazole structures. Studies
towards this area are in progress and will be reported in due
course.
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